NOVASTIM Application icon

NOVASTIM 1.0.0

58.1 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

NOVASTIM, developed and published by ObvioHealth, has released its latest version, 1.0.0, on 2023-12-30. This app falls under the Medical category on the Google Play Store and has achieved over 1 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

NOVASTIM APK available on this page is compatible with all Android devices that meet the required specifications (Android 6.0+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.obvio.claimit.ebt.saphstim

Updated: 1 year ago

Developer Name: ObvioHealth

Category: Medical

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing NOVASTIM on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

NOVASTIM 1.0.0
2023-12-30 / 58.1 MB / Android 6.0+

About this app

Welcome to the NOVASTIM study: Non-invasive Stimulation Therapy for Overactive Bladder: A Randomized Controlled Trial.

The purpose of this study is to help researchers who are hard at work developing new treatments for OAB. This study is being conducted to verify that saphenous nerve stimulation with the NiNA device is non-inferior to the use of medication in reducing the number of daily urgency urinary incontinence episodes 

The NOVASTIM app is a proprietary platform of ObvioHealth being used to manage a trial to
collect data regarding changes in OAB symptoms of participants. Changes in OAB symptoms will be measured at appropriate study time points using the following instruments: Bladder diary (3-day), OAB-q and other self-administered questionnaires. Additional assessments of subject satisfaction and preferences will be obtained via subject study surveys and questionnaires at various study time points. 

The NOVASTIM app will allow for ease of reporting on behalf of participant and gives direct communication to study team support for users without delay. By creating an opportunity to study the changing symptoms through self-administered questionnaires and instruments, it increases accessibility to participation while reducing overhead costs of physical sites.

The result? Robust data collection, increased compliance, faster time to completion, and
average cost savings of ~50% vs.traditional on-site trials.

Once deemed eligible, the participant will receive an email with the NOVASTIM download link and their login ID.

Upon download, the participants create a OAB CDUT account and complete the Informed
Consent process. A series of screens explains the parameters of the study, including:
• Privacy Policy
• Data Gathering & Usage
• Study Tasks & Surveys
• Time Commitment
• Option to Withdraw
Subjects will have the opportunity to connect with a member of the study team to ask questions prior to signing the informed consent form.

They will go on to complete three electronic questionnaire to further verify eligibility and collect demographics. After this is done, there will be an a 60-minute interview where the participant will be asked about their experiences with the app and main bladder diary.

There are no risks involved in this study because it involves a phone interview and an in-app electronic questionnaire.

New features

Initial submission for study app

App Permissions

Allows applications to open network sockets.
Allows applications to access information about networks.
Allows an app to use fingerprint hardware.
Allows an application to write to external storage.
Allows an application to read from external storage.
Allows an application to receive the ACTION_BOOT_COMPLETED that is broadcast after the system finishes booting.
Required to be able to access the camera device.
Allows access to the vibrator.
Allows an application to read the user's calendar data.
Allows an application to write the user's calendar data.
Allows using PowerManager WakeLocks to keep processor from sleeping or screen from dimming.
Allows applications to access information about Wi-Fi networks.